Sign in to view content

Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials

Katherine E Talcott, MD

Video
Published 2021

Related

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Relationship between Change in Visual Acuity and Change in Retinal Thickness during Treatment of Diabetic Macular Edema with Anti-VEGF
Daniel F. Rosberger, MD, PhD, MPH
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more